Novel strains of Salmonella typhimurium as potential vectors for gene delivery

FEMS Microbiology Letters

Volumn 238, Issue 2, 2004, Pages 345-351

  Michael, Agnieszka ^a   Stratford, Richard ^b   Khan, Shahid ^b   Dalgleish, Angus ^a   Pandha, Hardev ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UK   (United Kingdom)

Author keywords

DNA vaccine; Gene transfer; Salmonella typhimurium

Indexed keywords

DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE TARGETING; GENE TRANSFER; GENE VECTOR; HUMAN; HUMAN CELL; LIVER; MESENTERY LYMPH NODE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SALMONELLA TYPHIMURIUM; SPLEEN;

ANIMALS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; MICE; MICE, INBRED C57BL; PLASMIDS; SALMONELLA TYPHIMURIUM;

SALMONELLA TYPHIMURIUM;

EID: 4444375890     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.07.054     Document Type: Article

References (17)

1. S.N. Chatfield, G. Dougan, and M. Roberts Progress in the development of multivalent oral vaccines based on live attenuated Salmonella Modern Vaccinol. 1994 55 86
2. A. Darji, C.A. Guzman, B. Gerstel, P. Wachholz, K.N. Timmis, J. Wehland, T. Chakraborty, and S. Weiss Oral somatic transgene vaccination using attenuated S. typhimurium Cell 91 6 1997 765 775
3. D.A. Saltzman, C.P. Heise, D.E. Hasz, M. Zebede, S.M. Kelly, R. Curtiss 3rd, A.S. Leonard, and P.M. Anderson Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent Cancer Biother. Radiopharm. 11 2 1996 145 153
4. M. Urashima, H. Suzuki, Y. Yuza, M. Akiyama, N. Ohno, and Y. Eto An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium Blood 95 4 2000 1258 1263
5. R. Xiang, H.N. Lode, T.H. Chao, J.M. Ruehlmann, C.S. Dolman, F. Rodriguez, J.L. Whitton, W.W. Overwijk, N.P. Restifo, and R.A. Reisfeld An autologous oral DNA vaccine protects against murine melanoma Proc. Natl. Acad. Sci. USA 97 10 2000 5492 5497
6. S.K. Hoiseth, and B.A. Stocker Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines Nature 291 5812 1981 238 239
7. S.L. Marcus, J.H. Brumell, C.G. Pfeifer, and B.B. Finlay Salmonella pathogenicity islands: big virulence in small packages Microbes Infect. 2 2 2000 145 156
8. F. Garcia del Portillo, M.B. Zwick, K.Y. Leung, and B.B. Finlay Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells Proc. Natl. Acad. Sci. USA 90 1993 10511 10518
9. S.D. Mills, S.R. Ruschkowski, M.A. Stein, and B.B. Finlay Trafficking of porin-deficient Salmonella typhimurium mutants inside HeLa cells: ompR and envZ mutants are defective for the formation of Salmonella-induced filaments Infect. Immunol. 66 4 1998 1806 1811
10. A. Darji, S. zur Lage, A.I. Garbe, T. Chakraborty, and S. Weiss Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier FEMS Immunol. Med. Microbiol. 27 4 2000 341 349
11. D. Dreher, M. Kok, L. Cochand, S.G. Kiama, P. Gehr, J.C. Pechere, and L.P. Nicod Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells J. Leukoc. Biol. 69 4 2001 583 589
12. J.J. Donnelly, J.B. Ulmer, J.W. Shiver, and M.A. Liu DNA vaccines Annu. Rev. Immunol. 15 1997 617 648
13. E. Wang, G.Q. Phan, and F.M. Marincola T-cell-directed cancer vaccines: the melanoma model Expert. Opin. Biol. Ther. 1 2 2001 277 290
14. D.A. Saltzman, E. Katsanis, C.P. Heise, D.E. Hasz, V. Vigdorovich, S.M. Kelly, R. Curtiss 3rd, A.S. Leonard, and P.M. Anderson Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent? J. Pediatr. Surg. 32 2 1997 301 306
15. M.A. Stein, K.Y. Leung, M. Zwick, F. Garcia-del Portillo, and B.B. Finlay Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells Mol. Microbiol. 20 1 1996 151 164
16. Z. Hindle, S.N. Chatfield, J. Phillimore, M. Bentley, J. Johnson, C.A. Cosgrove, M. Ghaem-Maghami, A. Sexton, M. Khan, F.R. Brennan, P. Everest, T. Wu, D. Pickard, D.W. Holden, G. Dougan, G.E. Griffin, D. House, J.D. Santangelo, S.A. Khan, J.E. Shea, R.G. Feldman, and D.J. Lewis Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers Infect. Immunol. 70 7 2002 3457 3467
17. D.M. Cirillo, R.H. Valdivia, D.M. Monack, and S. Falkow Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival Mol. Microbiol. 30 1 1998 175 188